13F HOLDINGS REPORT
M28 Capital Management LP
Quarter ended Q4 2025 · Filed February 13, 2026 · Accession 0000902664-26-000993
Total Value
$137.6M
Positions
9
Other Managers
0
Confidential Omitted
No
Holdings (9)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | WAVE LIFE SCIENCES LTD | WVE | 5,664,548 | $96.3M | 70.00% |
| 2 | INVIVYD INC | IVVD | 9,248,250 | $22.8M | 16.60% |
| 3 | TG THERAPEUTICS INC | TGTX | 161,600 | $4.8M | 3.50% |
| 4 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 67,400 | $4.5M | 3.25% |
| 5 | FRACTYL HEALTH INC | GUTS | 1,856,117 | $4.1M | 2.97% |
| 6 | PROQR THRAPEUTICS N V | N71542109 | 1,019,498 | $2.1M | 1.50% |
| 7 | ROCKET PHARMACEUTICALS INC | RCKTW | 385,680 | $1.4M | 0.98% |
| 8 | SILENCE THERAPEUTICS PLC | SLNCF | 185,100 | $1.1M | 0.82% |
| 9 | CURIS INC | CRIS | 521,059 | $514,337 | 0.37% |